123 related articles for article (PubMed ID: 29061802)
1. MYD88 Inhibitor ST2825 Suppresses the Growth of Lymphoma and Leukaemia Cells.
Shiratori E; Itoh M; Tohda S
Anticancer Res; 2017 Nov; 37(11):6203-6209. PubMed ID: 29061802
[TBL] [Abstract][Full Text] [Related]
2. Disrupting myddosome assembly in diffuse large B‑cell lymphoma cells using the MYD88 dimerization inhibitor ST2825.
Wang X; Tan Y; Huang Z; Huang N; Gao M; Zhou F; Hu J; Feng W
Oncol Rep; 2019 Nov; 42(5):1755-1766. PubMed ID: 31432184
[TBL] [Abstract][Full Text] [Related]
3. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound.
Loiarro M; Capolunghi F; Fantò N; Gallo G; Campo S; Arseni B; Carsetti R; Carminati P; De Santis R; Ruggiero V; Sette C
J Leukoc Biol; 2007 Oct; 82(4):801-10. PubMed ID: 17548806
[TBL] [Abstract][Full Text] [Related]
4. Effect of ST2825 on the proliferation and apoptosis of human hepatocellular carcinoma cells.
Deng Y; Sun J; Zhang LD
Genet Mol Res; 2016 Mar; 15(1):15016826. PubMed ID: 26985932
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of myeloid differentiation primary response protein 88 provides neuroprotection in early brain injury following experimental subarachnoid hemorrhage.
Yan H; Zhang D; Wei Y; Ni H; Liang W; Zhang H; Hao S; Jin W; Li K; Hang CH
Sci Rep; 2017 Nov; 7(1):15797. PubMed ID: 29150630
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Inflammatory Cytokine Release from IL-1β and LPS-Stimulated PBMC Orchestrated by ST2825, a MyD88 Dimerisation Inhibitor.
Ramírez-Pérez S; Hernández-Palma LA; Oregon-Romero E; Anaya-Macías BU; García-Arellano S; González-Estevez G; Muñoz-Valle JF
Molecules; 2020 Sep; 25(18):. PubMed ID: 32967164
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of myeloid differentiation factor 88(MyD88) by ST2825 provides neuroprotection after experimental traumatic brain injury in mice.
Zhang HS; Li H; Zhang DD; Yan HY; Zhang ZH; Zhou CH; Ye ZN; Chen Q; Jiang TW; Liu JP; Hang CH
Brain Res; 2016 Jul; 1643():130-9. PubMed ID: 27155455
[TBL] [Abstract][Full Text] [Related]
8. Short-term MyD88 inhibition ameliorates cardiac graft rejection and promotes donor-specific hyporesponsiveness of skin grafts in mice.
He WT; Zhang LM; Li C; Li SY; Ding ZC; Fang ZM; Meng FY; Chen ZK; Zhou P
Transpl Int; 2016 Aug; 29(8):941-52. PubMed ID: 27125343
[TBL] [Abstract][Full Text] [Related]
9. Targeting MyD88: Therapeutic mechanisms and potential applications of the specific inhibitor ST2825.
Liu M; Kang W; Hu Z; Wang C; Zhang Y
Inflamm Res; 2023 Nov; 72(10-11):2023-2036. PubMed ID: 37814128
[TBL] [Abstract][Full Text] [Related]
10. A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia.
Yang G; Zhou Y; Liu X; Xu L; Cao Y; Manning RJ; Patterson CJ; Buhrlage SJ; Gray N; Tai YT; Anderson KC; Hunter ZR; Treon SP
Blood; 2013 Aug; 122(7):1222-32. PubMed ID: 23836557
[TBL] [Abstract][Full Text] [Related]
11. Myeloid differentiation factor 88 is up-regulated in epileptic brain and contributes to experimental seizures in rats.
Wang N; Han X; Liu H; Zhao T; Li J; Feng Y; Mi X; Zhang Y; Chen Y; Wang X
Exp Neurol; 2017 Sep; 295():23-35. PubMed ID: 28529112
[TBL] [Abstract][Full Text] [Related]
12. CRL3-SPOP ubiquitin ligase complex suppresses the growth of diffuse large B-cell lymphoma by negatively regulating the MyD88/NF-κB signaling.
Jin X; Shi Q; Li Q; Zhou L; Wang J; Jiang L; Zhao X; Feng K; Lin T; Lin Z; Zhuang H; Yang J; Hu C; Zhang L; Shen L; Lu Y; Zhu J; Wang H; Qi H; Meng X; Xi Y; Pan J; Fang S; Tian H; Zhou C; Zhang P; Gao K; Zhao SM; Li Y; Gong Z; Wang C
Leukemia; 2020 May; 34(5):1305-1314. PubMed ID: 31776466
[TBL] [Abstract][Full Text] [Related]
13. The MyD88 inhibitor, ST2825, induces cell cycle arrest and apoptosis by suppressing the activation of the NF‑κB/AKT1/p21 pathway in pancreatic cancer.
Lu S; He T; Zhang Y; Zhou B; Zhang Q; Yan S
Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37326109
[TBL] [Abstract][Full Text] [Related]
14. ST2825, independent of MyD88, induces reactive oxygen species-dependent apoptosis in multiple myeloma cells.
Nakamura H; Arihara Y; Usami M; Takada K
Biochem Biophys Rep; 2024 Jul; 38():101681. PubMed ID: 38455592
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Toll-like receptor/interleukin 1 receptor pathway in human diseases: rational design of MyD88 inhibitors.
Loiarro M; Ruggiero V; Sette C
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):222-6. PubMed ID: 23490990
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
[TBL] [Abstract][Full Text] [Related]
17. Redox DAPK1 destabilizes Pellino1 to govern inflammation-coupling tubular damage during septic AKI.
Hu BC; Wu GH; Shao ZQ; Zheng Y; Liu JQ; Zhang R; Hong J; Yang XH; Sun RH; Mo SJ
Theranostics; 2020; 10(25):11479-11496. PubMed ID: 33052227
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines.
Yeo AT; Chennamadhavuni S; Whitty A; Porco JA; Gilmore TD
Molecules; 2015 Apr; 20(5):7474-94. PubMed ID: 25915462
[TBL] [Abstract][Full Text] [Related]
19. A Novel Aziridine-based Bruton's Tyrosine Kinase Inhibitor Induces Apoptosis Through Down-regulation of p65/RelA Phosphorylation on Serine 536 and ERK1/2 in Mantle Cell Lymphoma.
Romanchikova N; Strods A; Strazdina J; Strumfs B; Trapencieris P
Anticancer Res; 2016 Nov; 36(11):6133-6140. PubMed ID: 27793942
[TBL] [Abstract][Full Text] [Related]
20. Constitutive association of MyD88 to IRAK in HTLV-I-transformed T cells.
Mizobe T; Tsukada J; Higashi T; Mouri F; Matsuura A; Tanikawa R; Minami Y; Yoshida Y; Tanaka Y
Exp Hematol; 2007 Dec; 35(12):1812-22. PubMed ID: 17920759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
